Mackenzie Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,212
| Closed | -$11.9K | – | 1570 |
|
|
2023
Q1 | $11.9K | Hold |
1,212
| – | – | ﹤0.01% | 1496 |
|
|
2022
Q4 | $22.7K | Hold |
1,212
| – | – | ﹤0.01% | 1395 |
|
|
2022
Q3 | $25K | Hold |
1,212
| – | – | ﹤0.01% | 1398 |
|
|
2022
Q2 | $25K | Buy |
1,212
+263
| +28% | +$5.43K | ﹤0.01% | 1429 |
|
|
2022
Q1 | $41K | Hold |
949
| – | – | ﹤0.01% | 1377 |
|
|
2021
Q4 | $57K | Sell |
949
-60
| -6% | -$3.6K | ﹤0.01% | 1392 |
|
|
2021
Q3 | $87K | Buy |
+1,009
| New | +$87K | ﹤0.01% | 1380 |
|
|
2015
Q2 | – | Sell |
-2,325
| Closed | -$228K | – | 829 |
|
|
2015
Q1 | $228K | Buy |
2,325
+433
| +23% | +$42.5K | ﹤0.01% | 749 |
|
|
2014
Q4 | $208K | Buy |
1,892
+109
| +6% | +$12K | ﹤0.01% | 715 |
|
|
2014
Q3 | $211K | Buy |
+1,783
| New | +$211K | ﹤0.01% | 687 |
|